Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Clinical trial NCT04991116 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04991116
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2028-12-01
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.